MDM2 and cancer: Considering the complexity of interactions between MDM2 and its partners in cancer cells, there are ongoing efforts in our lab to further understand the mechanisms of action for MDM2 inhibitors, such as SP141, focusing on the inflammation and oncogene pathways.